[ad_1]
In hospitals, patients treated with COVID-19 who take aspirin daily have a lower risk of developing complications, in the intensive care unit and of dying.
This was demonstrated by a study conducted by researchers at the University of Maryland School of Medicine.
The study, published in the journal Anesthesia and Analgesia, found that coronavirus patients who received daily low-dose aspirin for vascular disease were less likely to be in the intensive care unit to be hooked up to a mechanical ventilator.
According to scitechdaily.com, people who take aspirin have a better chance of surviving the infection.
The researchers say there is “cautious optimism” that this inexpensive and readily available drug may help prevent complications from COVID-19. It is true that this research by scientists must be confirmed by a randomized clinical trial.
About a quarter of the 412 patients (the researchers analyzed their data) received a low-dose aspirin, about 81 milligrams, every day. The average age of the people is 55 years.
Aspirin has been shown to be as high as 44 percent. reduce the likelihood that a person will need artificial lung ventilation by 43 percent. reduces the risk of being in the intensive care unit. The researchers found that aspirin use was associated with a 47% lower risk of death from COVID-19.
[ad_2]
